1484 An interplay between innate/adaptive/humoral immunity leads to increased immunogenicity of melanoma vs. non-melanoma derived brain metastases

作者
Alberto Mendoza,Daria M. Kessler,Douglas Allen Hanes,Ludmila Danilova,Ethan Dettmann,Kai Rau,Yueqin Quan,Stacey L. Stern,Russell C. Rockne,Daniel F. Kelly,Garni Barkhoudarian,Kim Allyson Margolin,Steven E. Kolker,Maria Libera Ascierto
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:: A1648-A1648
标识
DOI:10.1136/jitc-2023-sitc2023.1484
摘要

Background Brain metastases (BrMs) are a devastating complication of solid tumors. Despite improvements in tumor detection and local treatment as well as the introduction of new therapies including immune checkpoint blockade (ICB) and targeted therapies, the clinical benefit is observed only for a subset of BrMs patients.1–3 A better understanding of this disease is needed to develop more effective patient selection strategies and therapeutics. Methods In this study, multidisciplinary molecular and proteomic approaches were applied on to the peripheral blood and tumor tissues derived from primary lesions and BrMs from patients with melanoma, lung, breast, and renal cancer to evaluate in depth the tumor immune portrait behind BrMs biology. Results The tumor microenvironment (TME) of melanoma brain metastasis (MBM) appeared to be less immunogenic when compared to the TME of primary melanoma (PM), based on less infiltration of NK and NKT cells. However, higher infiltration of CD8+, antigen presenting cells, and B cells was observed in MBM when compared to BrMs derived from other solid tumors (non-MBM). Conversely, increased infiltration of Tregs and neutrophils was found in non-MBM compared with MBM. Interestingly, the presence of immature early tertiary lymphoid structures (TLS), as another hallmark of the TME of MBM, was supported by molecular and proteomic evaluations. Furthermore, proteomic analysis revealed higher infiltration of CD8+ and CD20+ cells in MBM to be associated with longer overall survival (OS). Curiously, the presence of immature early TLS structures in a MBM patient with longer OS compared to a MBM case with lower OS also emphasizes the potential influence of TLS formation in MBM patient survival and/or response to immunotherapy. These observations suggest that presence of TLS may have a strong association or even play a functional role in the immune control of MBM. Conclusions Taken together these results suggest that the TME of BrMs plays a pivotal role in the pathogenesis and therapeutic resistance of BrMs derived from different solid tumors. Acknowledgements The authors thank patients, their families, the Rosalie and Harold Rae Brown Family Foundation and the Borstein Family Foundation for their support. References Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. New England Journal of Medicine 2018;379:722–730. Tawbi HA, Forsyth PA, Hodi FS, Algazi AP, Hamid O, Lao CD, Moschos SJ, Atkins MB, Lewis K, Postow MA. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. The Lancet Oncology 2021;22:1692–1704. Goldberg SB, Schalper KA, Gettinger SN, Mahajan A, Herbst RS, Chiang AC, Lilenbaum R, Wilson FH, Omay SB, James BY. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. The Lancet Oncology 2020;21:655–663. Ethics Approval Samples were procured under studies approved by Providence Saint Joseph Health Institutional Review Board or Western Copernicus Group Institutional Review Board. All specimens evaluated were derived from consenting patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
经十路以东的应助被皮卡布采纳,获得10
2秒前
Huang完成签到 ,获得积分10
2秒前
科研通AI6.2的应助被皮卡布采纳,获得10
3秒前
3秒前
3秒前
3秒前
4秒前
挽风发布了新的文献求助10
4秒前
1733发布了新的文献求助20
5秒前
Orange的应助被小沈采纳,获得10
5秒前
gfydsl发布了新的文献求助10
6秒前
酷波er的应助被雾散采纳,获得10
7秒前
7秒前
8秒前
8秒前
经十路以东的应助被李佳佳采纳,获得10
8秒前
8秒前
9秒前
伍寒烟发布了新的文献求助10
9秒前
克里斯蒂娜完成签到 ,获得积分10
10秒前
烟花的应助被优雅尔芙采纳,获得10
11秒前
11秒前
Hello的应助被pokexuejiao采纳,获得20
11秒前
qqqqqqqqqq发布了新的文献求助50
12秒前
wellforever发布了新的文献求助10
12秒前
13秒前
13秒前
东风的应助被陈琛琛采纳,获得30
14秒前
14秒前
犹豫忆南发布了新的文献求助10
14秒前
14秒前
伍寒烟完成签到,获得积分10
14秒前
耳喃完成签到,获得积分10
15秒前
15秒前
柯基完成签到,获得积分10
16秒前
川里九樱发布了新的文献求助10
16秒前
prank完成签到,获得积分10
18秒前
美好含巧发布了新的文献求助10
19秒前
潇洒依白发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264